KZR logo
KZR NASDAQ US

Kezar Life Sciences, Inc. - Common Stock

Healthcare · Biotechnology Website · IPO Jun 2018
$7.40
▲ +$0.00 (+0.00%)
Vol 53K
3
Quality Score
fail
Mkt Cap
$46.1M
ROE
-64.2%
Margin
-1254.2%
D/E
8.02
Beta
0.55
52W
$4–$7

Wall Street Consensus

10 analysts · Apr 2026
1
Strong Buy
3
Buy
6
Hold
0
Sell
0
Strong Sell
40.0%
Buy Rating

Price Chart

Similar Stocks

ACRV
Acrivon Therapeutics Inc
$76.0M
ACTU
Actuate Therapeutics Inc
$142.2M
OKUR
Onkure Therapeutics Inc
$39.3M
ICCC
ImmuCell Corp
P/E 23.9
$55.6M
TIL
Instil Bio Inc
$74.6M
TCRX
TScan Therapeutics Inc
$56.7M
MGX
Metagenomi Therapeutics Inc
$60.8M
INKT
Mink Therapeutics Inc
$52.3M

Earnings

Beat rate: 80.0%
Next Report May 11, 2026
EPS Estimate: $-0.82
Quarter EPS Est EPS Act Surprise
Mar 2026 $-0.82 — —
Dec 2025 $-1.24 $-1.99 $-0.74
Sep 2025 $-2.10 $-1.53 +$0.57
Jun 2025 $-2.41 $-1.87 +$0.54

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) -64.2% -46.4% -46.4% -46.4% -64.2% -64.2%
P/E (TTM) — — — — — —
Net Margin — -1254.2% -1254.2% -1254.2% -1254.2% -1254.2%
Gross Margin — — — — — —
D/E Ratio 8.63 8.63 8.63 8.63 8.63 8.02
Current Ratio 7.29 7.29 7.29 7.29 7.29 7.07

Key Ratios

ROA (TTM)
-52.7%
P/S (TTM)
9.50
P/B
0.4
EPS (TTM)
$-9.79
CF/Share
$-1.20
52W High
$6.95
52W Low
$3.53
$3.53 52-Week Range $6.95

How does KZR compare to Biotechnology peers?

Peer group: Micro-cap Biotechnology (All) · 528 companies

KZR AAPG ABEO ABOS ABP

KZR valuation vs Biotechnology peers

P/E ratio
—
▼ 0% below peers (18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
9.5
▼ 26% below peers (12.9)
vs Peers
vs Industry
Pricier
P/B ratio
0.4
▼ 83% below peers (2.5)
vs Peers
vs Industry
Undervalued
Div yield
—
▼ 0% below peers (0.0%)
vs Peers
vs Industry
Low yield

KZR profitability vs Biotechnology peers

ROE
-64.2%
▲ 5% above peers (-67.3%)
vs Peers
vs Industry
In line
Net margin
-1254.2%
▼ 337% below peers (-286.8%)
vs Peers
vs Industry
Weak
Gross margin
—
▼ 0% below peers (78.6%)
vs Peers
vs Industry
In line
ROA
-52.7%
▼ 13% below peers (-46.7%)
vs Peers
vs Industry
In line

KZR financial health vs Biotechnology peers

D/E ratio
8.0
▼ 0% below peers (0.0)
vs Peers
vs Industry
High debt
Current ratio
7.1
▲ 59% above peers (4.4)
vs Peers
vs Industry
Below avg
Beta
0.6
▼ 43% below peers (1.0)
vs Peers
vs Industry
More volatile

KZR fundamentals radar

KZR Peer median Industry

KZR profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

KZR vs peers: key metrics

Latest News

No related news yet